Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2023-09-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions are:
1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions?
The secondary research questions are:
2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm?
3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions?
4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions?
5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata?
6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In one of this hospitals, Region Skåne, the intervention will be consultation-based. Individuals with intractable self-harm will be offered an assessment and review of all medical records which will result in a individualized intervention plan. Interventions include further assessments and supporting the existing treatment providers, families or caregivers. Recurring network-meetings will occur every three months as well as at he end of the intervention.
Data collection will include self-report measures as well as information from charts and national och regional registries.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Individuals with current severe, imminent and lethal self-harm with a history of at least two interventions without sufficient reduction of self-harm or suffering.
National specialized medical care unit for severe self-harm behaviour-Consultation model
Extensive assessments. Consultation and training for existing treatment providers and caregivers. Network-meetings for providers and caregivers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
National specialized medical care unit for severe self-harm behaviour-Consultation model
Extensive assessments. Consultation and training for existing treatment providers and caregivers. Network-meetings for providers and caregivers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Not able to complete measures or interviews
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of Psychology. Lund University.
UNKNOWN
Department of Clinical Sciences, Malmö. Faculty of Medicine, Lund University.
UNKNOWN
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Highly Specialized Unit for Self-Harm Behaviours, Skåne
Lund, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Magnus Nilsson, PhD
Role: primary
Sofie Westling, MD/PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dnr 2023-01650-01
Identifier Type: -
Identifier Source: org_study_id